HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix

scientific article published on 19 December 2012

HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YGYNO.2012.12.013
P698PubMed publication ID23262207
P5875ResearchGate publication ID233975344

P50authorChris J L M MeijerQ90379336
Peter J F SnijdersQ90768556
P2093author name stringTheo J M Helmerhorst
Frank Smedts
Patricia Ewing
Astrid Baalbergen
P2860cites workGlobal cancer statisticsQ22241238
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideQ29617514
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervixQ30978718
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypesQ33950978
Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histologyQ34990478
Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screeningQ35103103
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinomaQ35745823
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The NetherlandsQ36613522
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam areaQ36671743
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United StatesQ36983254
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervixQ37826532
Cervical adenocarcinoma: moving towards better preventionQ37943650
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in EuropeQ38023288
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomasQ38503187
Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.Q40182618
Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervixQ43998286
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyQ45206974
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationQ47860026
Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.Q51023169
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.Q51257523
HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.Q51550773
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.Q53402217
High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.Q54368974
HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.Q54438467
Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.Q54544360
Incidence Trends of Adenocarcinoma of the Cervix in 13 European CountriesQ57027324
Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in CanadaQ57089348
Classification of cervical carcinomaQ70178434
Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reactionQ72272090
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialQ81404025
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialQ82586477
p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infectionQ84778960
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectadenocarcinomaQ356033
P304page(s)530-534
P577publication date2012-12-19
P1433published inGynecologic OncologyQ5625182
P1476titleHPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix
P478volume128